Netherlands· NL-944d3f2d0f95
Tauvid 1.900 MBq/ml oplossing voor injectie
A flortaucipir (18f) product containing flortaucipir (18f), registered in Netherlands by Eli Lilly Nederland B.V.. The same ATC class is registered in 7 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Flortaucipir (18f) is registered in 7 of 19 countries.
Countries holding a registration under ATC V09AX07 (flortaucipir (18f)), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 5 of them publish a price we can compare per daily dose
Flortaucipir (18f) · ATC V09AX07
7 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- FLORTAUCIPIR (18F)
- Manufacturer
- Eli Lilly Nederland B.V.
- Country
- Netherlands (NL)
- ATC code
- V09AX07
- ATC class
- Flortaucipir (18F)
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/24/1799
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Flortaucipir (18f) in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumTauvid 1900 MBq/mlEli Lilly Nederland
- CzechiaTAUVIDEli Lilly Nederland B.V., Utrecht
- FinlandTauvidEli Lilly Nederland B.V
- IcelandTauvidEli Lilly Nederland B.V.*
- SwedenTauvid 1900 MBq/ml Injektionsvätska, lösningEli Lilly Nederland B.V.
- IrelandTauvid 800 MBq/mL solution for injectionEli Lilly Nederland B.V.
- United StatesTAUVIDEli Lilly and Company
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Tauvid
- Liechtenstein · Tauvid
- Norway · Tauvid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2620f98e-9904-4e53-a8d1-ebb4e39c345b GET /v1/drugs/2620f98e-9904-4e53-a8d1-ebb4e39c345b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor injectie",
"route": "Intraveneus gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/tauvid-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Flortaucipir (18 F)",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp131281",
"excipients": [
"DINATRIUMWATERSTOFFOSFAAT 0-WATER (E 339)",
"ETHANOL",
"NATRIUMCHLORIDE",
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"FLORTAUCIPIR (18F)"
],
"leaflet_url": null,
"authorised_at": "2024/08/22",
"procedure_number": "EMEA/H/C/006064",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/24/1799",
"additional_monitoring": "Y"
}See everything about flortaucipir (18f).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.